What is the screening recommendation for osteoporosis in women?

The recommendation to begin osteoporosis screening in women at age 65 is grounded in research that indicates a significant increase in fracture risk as women age, particularly after this age. Osteoporosis is a condition characterized by weak and brittle bones, making individuals more susceptible to fractures. The risk of developing osteoporosis and sustaining fractures, especially hip and vertebral fractures, sharply rises in postmenopausal women, who typically experience a decline in bone density due to decreased estrogen levels.

Screening at age 65 allows for the identification of women who may benefit from preventive measures, such as lifestyle modifications or medications that help maintain bone density and reduce fracture risk. This approach is aligned with guidelines from major health organizations, including the U.S. Preventive Services Task Force and the National Osteoporosis Foundation. By focusing screening efforts on this age group, healthcare providers can effectively target interventions and manage health outcomes related to osteoporosis.